What Green Rock does

Green Rock Gestora de Recursos Ltda is an independent venture capital and private equity manager headquartered in São Paulo, Brazil, focused exclusively on the healthcare sector across Latin America. Founded in 2017 as an investment vehicle for the Salomão and Zoppi families — founders of the Salomão Zoppi Diagnostics laboratory — the firm professionalized in 2023 by spinning off its family-office activities into a separate entity called 'Black River'. Green Rock invests at the Seed, Series A, and early private equity stages into companies with validated products and initial revenue, deploying approximately R$200 million of proprietary capital across 20+ portfolio companies and evaluating more than 1,000 healthcare businesses annually. The firm has no proprietary technology; its core offering is capital plus strategic support, with portfolio coverage spanning medical education (Sanar), clinical research (Azidus), customer experience management (Track.co), occupational health (Welbe, Mexico), elderly care (Sanii), corporate medication benefits (Omni Saúde), brain-health monitoring (Brain4Care), medical cannabis (Endogen), biotech (Mirscience Therapeutics), and health-integration platforms (Nuria). Revenue derives from traditional VC/PE fund management economics — management fees on committed capital and carried interest from exits — though specific fund terms and LP composition are not publicly disclosed. Distribution is entirely network-based, leveraging the founding families' relationships with Brazilian hospital networks, clinics, diagnostic laboratories, insurers, biotech companies, and an Investment Committee staffed by senior healthcare operators from Grupo SulAmérica, Rede D'Or, Amil, Hapvida, Siemens Healthineers, KPMG, and ANS.

Name

Green Rock

Legal name

Green Rock Gestora de Recursos Ltda

Website

https://greenrock.vc

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Green Rock is an independent São Paulo–based venture capital and private equity manager that invests Seed through early private equity stages exclusively in healthcare companies across Brazil and Latin America, deploying proprietary capital plus strategic support from a network of senior healthcare operators.

Ownership category

akta.pro rank

Product category

Venture Capital and Private Equity (Healthcare)

NAICS

Funds, Trusts, and Other Financial Vehicles (525), Other Financial Vehicles (52599)

SIC

Investment Advice (6282)

akta.pro primary industry

Emerging Manager / Seeding Platforms (Multi-Manager) (FSANAGAF)

akta.pro secondary industry

Emerging Managers / Seeding Platforms (FSAHAKAI)

Keywords

• Venture capital
• Healthcare investing
• Private equity
• Seed funding
• Healthtech startups

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Fund Management: Green Rock generates revenue through traditional VC/PE fund management structures, including management fees on committed capital and carried interest (performance fees) from successful portfolio company exits. The firm has made 20+ investments in health companies and evaluates 1000+ healthcare businesses annually.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Green Rock is an independent venture capital and private equity asset manager that invests in early-stage healthcare companies in Brazil and Latin America. The firm deploys capital primarily at Seed, Series A, and Early Private Equity stages, and supplements financial capital with strategic guidance, healthcare industry connections, and operational support to portfolio founders. It evaluates 1,000+ healthcare businesses annually and has made 20+ direct investments backed by R$200M of proprietary capital.

Product overview

Green Rock is a Venture Capital and Private Equity investment firm specializing in the healthcare sector in Brazil and Latin America. As an independent asset manager, the firm does not offer a software product or technology platform; instead, it provides investment management services, deploying capital in high-potential healthcare companies across various stages (Seed, Series A, and Early Private Equity). The firm connects investors, entrepreneurs, and specialists to create the future of healthcare, going beyond financial capital to provide guidance and connections to founders. Green Rock's portfolio spans multiple health verticals including disease prevention, health system efficiency, emerging therapies, mental health, applied high technology, and access and inclusion to healthcare.

Differentiator

Problem solved

Functional benefit

Products and services

• Seed and Series A Healthcare Investments Early-stage equity capital investments (Seed, Series A) in Brazilian and Latin American healthcare startups with validated products/services and initial revenue, for founding teams seeking an institutional investment partner.
• Early Private Equity Healthcare Investments Later-stage private equity investments in healthcare companies in Brazil and Latin America, executed selectively alongside the firm's Seed and Series A activity.
• Portfolio Company Strategic Support Beyond-capital offering for portfolio founders that provides strategic guidance, healthcare industry connections, regulatory and business-model expertise, and senior-level mentorship from doctors, executives and healthcare entrepreneurs.
• Fund Management for Limited Partners Management of healthcare-focused venture capital and private equity funds on behalf of limited partners, earning management fees on committed capital and carried interest on successful exits.

Quantifiable outcome

• R$200 million in own capital invested since first fund
• +3 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Brazilian Healthcare Business GroupscoreOthersGreen Rock maintains close relationships with hospital networks, clinics, laboratories, insurance companies, industry players and biotechnology companies in Brazil. They emphasize independence from these groups while leveraging connections for deal flow and portfolio support.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Valor Capital Group: US-Brazil cross-border VC investing in Brazilian founders including healthcare. Comparable on stage and country focus; brings cross-border LP and exit capabilities that are adjacent to Green Rock's mandate.
• ALLVP: Mexico-anchored early-stage VC with active healthcare investments across LatAm. Comparable in stage and regional breadth; complements Green Rock's Brazil-heavy footprint with deeper Mexican and Andean reach.
• Vox Capital: Brazilian early-stage VC investing in impact-driven businesses including healthcare access. Similar stage profile and Brazil focus; both firms target underserved/structural themes in healthtech.
• Kaszek Ventures: Largest LatAm-focused VC fund with active healthcare investments alongside broader sector exposure. Comparable in stage (seed/Series A) and geography, though not healthcare-only — represents the broader competitive set Green Rock competes for healthcare deals against.
• Monashees: One of the largest Brazilian VCs with healthcare exposure in its portfolio. Directly comparable on stage and geography; competes with Green Rock for healthcare allocations though not healthcare-specialized.
• Atlantico: Pan-LatAm early-stage VC with healthcare among its core verticals. Comparable in stage and geography; serves as a broader incumbent LatAm peer for healthcare deal flow.
• Canary: Brazilian early-stage VC with multiple healthcare investments. Similar seed/Series A focus and Brazil/LatAm orientation; competes for the same founder pool in Brazilian healthtech.
• DNA Capital: Brazilian venture capital firm focused exclusively on healthtech investing across multiple stages. Highly comparable to Green Rock in thesis (healthcare-only), stage focus (seed/early), and geographic focus (Brazil/LatAm).

Others

• Salomão Zoppi Diagnostics: Brazilian diagnostics laboratory co-founded by Green Rock's co-founders. While not a financial peer, it is the strategic ecosystem partner whose principals sit on Green Rock's Strategic Committee, supplying deal flow and clinical diligence support.

Broad incumbents

• Bradesco (Private Equity / BBI): Large Brazilian financial conglomerate with PE/VC arms that invest in healthcare at later stages than Green Rock. Represents the institutional incumbent alternative LPs may compare Green Rock against when sizing healthcare allocations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/greenrock-vc

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments32 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Green Rock